Monthly Archives: September 2016

PEGfilgrastim (Neulasta) Approved for Treatment of Acute Radiation Syndrome

In November 2015, the Food and Drug Administration approved the use of Amgen’s pegfilgrastim (Neulasta) to increase survival of people acutely exposed to high-dose radiation that damages the bone marrow, which will improve access to the drug in the event … Continue reading

Posted in Biologic, Blogs, cancer, chemotherapy | Leave a comment

The next stop for PEGylated protein drugs: Biosimilar

Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor analog filgrastim. It serves to stimulate the level of white blood cells. Pegfilgrastim has a human half-life of 15 to 80 hours, much longer than the parent filgrastim … Continue reading

Posted in Biologic, Biosimilar, Blogs, cancer, chemotherapy, pegylation | Leave a comment

MIT is Utilizing Color in Their Fluorescent Polymer Gels

According to MIT News, researchers at MIT are developing fluorescent polymer gels that they hope detect structural failure in energy equipment. When the gels are disrupted in any way, they will change colors which will help those using the equipment … Continue reading

Posted in Blogs | Leave a comment